# Gabapentin for Carpal Tunnel Syndrome

> **NCT00137735** · PHASE3 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 150 (actual)

## Conditions studied

- Carpal Tunnel Syndrome

## Interventions

- **DRUG:** Gabapentin
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00137735
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2007-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00137735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00137735, "Gabapentin for Carpal Tunnel Syndrome". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00137735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*